These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. New biologic therapy for systemic lupus erythematosus. Ding HJ; Gordon C Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092 [TBL] [Abstract][Full Text] [Related]
7. A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients. Chastek B; White J; Van Voorhis D; Tang D; Stolshek BS Adv Ther; 2016 Apr; 33(4):626-42. PubMed ID: 26970958 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions. Bays AM; Gardner G Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612 [TBL] [Abstract][Full Text] [Related]
9. New treatments for inflammatory rheumatic disease. Selmi C; Generali E; Massarotti M; Bianchi G; Sciré CA Immunol Res; 2014 Dec; 60(2-3):277-88. PubMed ID: 25381481 [TBL] [Abstract][Full Text] [Related]
10. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis? Baker KF; Isaacs JD Ann Rheum Dis; 2018 Feb; 77(2):175-187. PubMed ID: 28765121 [TBL] [Abstract][Full Text] [Related]
11. [Innovative Methods of Some Systemic Autoimmune Diseases Treatment]. Mazurov VI; Trofimov EA Vestn Ross Akad Med Nauk; 2015; (2):165-8. PubMed ID: 26234088 [TBL] [Abstract][Full Text] [Related]
12. Additional Improvements in Clinical Response From Adjuvant Biologic Response Modifiers in Adults With Moderate to Severe Systemic Lupus Erythematosus Despite Immunosuppressive Agents: A Systematic Review and Meta-analysis. Shamliyan TA; Dospinescu P Clin Ther; 2017 Jul; 39(7):1479-1506.e45. PubMed ID: 28673504 [TBL] [Abstract][Full Text] [Related]
14. Biologic treatment in Sjögren's syndrome. Sada PR; Isenberg D; Ciurtin C Rheumatology (Oxford); 2015 Feb; 54(2):219-30. PubMed ID: 25342375 [TBL] [Abstract][Full Text] [Related]
15. Systemic rheumatic diseases: From biological agents to small molecules. Sarzi-Puttini P; Ceribelli A; Marotto D; Batticciotto A; Atzeni F Autoimmun Rev; 2019 Jun; 18(6):583-592. PubMed ID: 30959214 [TBL] [Abstract][Full Text] [Related]
16. Safety issues and concerns of new immunomodulators in rheumatology. Selmi C; Ceribelli A; Naguwa SM; Cantarini L; Shoenfeld Y Expert Opin Drug Saf; 2015 Mar; 14(3):389-99. PubMed ID: 25518908 [TBL] [Abstract][Full Text] [Related]
17. The use of biologic therapies in the treatment of rheumatoid arthritis. Wang D; Li Y; Liu Y; Shi G Curr Pharm Biotechnol; 2014; 15(6):542-8. PubMed ID: 25213363 [TBL] [Abstract][Full Text] [Related]
18. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus. Trindade VC; Carneiro-Sampaio M; Bonfa E; Silva CA Paediatr Drugs; 2021 Jul; 23(4):331-347. PubMed ID: 34244988 [TBL] [Abstract][Full Text] [Related]
19. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491 [TBL] [Abstract][Full Text] [Related]
20. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]